Ondine announces investor-led financing | 30-Nov-2023 | 18:40 | RNS |
Photodisinfection recommended as Standard of Care | 16-Nov-2023 | 07:00 | RNS |
Half-year Report | 25-Sep-2023 | 09:00 | RNS |
Notice of Results and Investor Presentation | 30-Aug-2023 | 07:00 | RNS |
Issue of Equity and TVR | 21-Aug-2023 | 07:00 | RNS |
Ondine commences first NHS Steriwave® pilot | 01-Aug-2023 | 07:00 | RNS |
Corporate Update | 07-Jul-2023 | 17:58 | RNS |
Result of AGM | 25-May-2023 | 07:00 | RNS |
Annual Report for the Year Ended 31 December 2022 | 23-May-2023 | 07:00 | RNS |
Full Year Results | 10-May-2023 | 07:09 | RNS |
Notice of Results and Investor Presentation | 03-May-2023 | 15:30 | RNS |
Notice of AGM | 03-May-2023 | 08:02 | RNS |
Issue of Equity | 03-May-2023 | 07:56 | RNS |
Progress Update | 17-Apr-2023 | 07:00 | RNS |
Ottawa hospital presents Steriwave study results | 03-Mar-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 6.75p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 16.50 |
52 Week Low | 5.13 |
Volume | 205,851 |
Shares Issued | 277.29m |
Market Cap | £18.72m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:59 | 840 @ 7.00p |
15:59 | 200 @ 7.00p |
15:59 | 33 @ 6.50p |
15:27 | 760 @ 6.93p |
12:53 | 100,000 @ 6.76p |
Chair | Jean Charest |
CEO | Carolyn Cross |
You are here: research